Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating an updated version of the page content and replacing the previous Revision: v3.5.3.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows a new revision version (v3.5.3) replacing the previous v3.5.2, indicating a small update to the page content or metadata. This change updates the revision history but does not alter substantive study information.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to study content or page functionality.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page footer.SummaryDifference0.1%

- Check111 days agoChange DetectedRevision: v3.4.2 was added and notices for Revision: v3.4.1 and the government funding lapse were removed.SummaryDifference0.4%

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.